AI Summary & Key Takeaways
AI InsightWe detected statistically significant improvements in the outcome measurements at thepost-injection second and 12th weeks (p
📌 3 Key Takeaways
Abstract
This study aims to investigate the efficacy of transforaminal epidural steroid injection (TFESI) on low back pain relief and functionalimpairments and whether pain provocation during injection has an effect on pain relief in mid-term.Patients and methods: The study, which was conducted between September 2012 and September 2013, included 62 patients with low back pain(38 males, 24 females; median age 45 years; min 22 - max 88 years). All injections were applied under C-arm fluoroscopy guidance, using a mix ofbetamethasone and lidocaine. A 100 mm Visual Analog Scale (VAS) for pain, Oswestry Disability Index (ODI), and Short Form-36 were administeredbefore the injection, and at post-injection second and 12th weeks. Presence of any pain provocation was questioned during injection.Results: The most frequent level of intervention was L5 level. Median initial VAS score was 80.0 (50.0;100.0) mm, which was measured as45.0 (0.0;90.0) mm and 30.0 (0.0;100.0) mm at the post-injection second and 12th weeks, respectively. Median initial ODI score was 25.0 (9.0;43.0)points, which was measured as 17.0 (3.0;38.0) and 12.5 (1.0;38.0) points at the post-injection second and 12th weeks, respectively. All subgroup scoresof SF-36 improved significantly during the follow-up period. We detected statistically significant improvements in the outcome measurements at thepost-injection second and 12th weeks (p